Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Vaccine Market Size Analysis from 2022 to 2027
1.5.1 Global Vaccine Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Vaccine Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Vaccine Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Vaccine Industry Impact
Chapter 2 Global Vaccine Competition by Types, Applications, and Top Regions and Countries
2.1 Global Vaccine (Volume and Value) by Type
2.1.1 Global Vaccine Consumption and Market Share by Type (2016-2021)
2.1.2 Global Vaccine Revenue and Market Share by Type (2016-2021)
2.2 Global Vaccine (Volume and Value) by Application
2.2.1 Global Vaccine Consumption and Market Share by Application (2016-2021)
2.2.2 Global Vaccine Revenue and Market Share by Application (2016-2021)
2.3 Global Vaccine (Volume and Value) by Regions
2.3.1 Global Vaccine Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Vaccine Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Vaccine Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Vaccine Consumption by Regions (2016-2021)
4.2 North America Vaccine Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Vaccine Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Vaccine Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Vaccine Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Vaccine Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Vaccine Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Vaccine Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Vaccine Sales, Consumption, Export, Import (2016-2021)
4.10 South America Vaccine Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Vaccine Market Analysis
5.1 North America Vaccine Consumption and Value Analysis
5.1.1 North America Vaccine Market Under COVID-19
5.2 North America Vaccine Consumption Volume by Types
5.3 North America Vaccine Consumption Structure by Application
5.4 North America Vaccine Consumption by Top Countries
5.4.1 United States Vaccine Consumption Volume from 2016 to 2021
5.4.2 Canada Vaccine Consumption Volume from 2016 to 2021
5.4.3 Mexico Vaccine Consumption Volume from 2016 to 2021
Chapter 6 East Asia Vaccine Market Analysis
6.1 East Asia Vaccine Consumption and Value Analysis
6.1.1 East Asia Vaccine Market Under COVID-19
6.2 East Asia Vaccine Consumption Volume by Types
6.3 East Asia Vaccine Consumption Structure by Application
6.4 East Asia Vaccine Consumption by Top Countries
6.4.1 China Vaccine Consumption Volume from 2016 to 2021
6.4.2 Japan Vaccine Consumption Volume from 2016 to 2021
6.4.3 South Korea Vaccine Consumption Volume from 2016 to 2021
Chapter 7 Europe Vaccine Market Analysis
7.1 Europe Vaccine Consumption and Value Analysis
7.1.1 Europe Vaccine Market Under COVID-19
7.2 Europe Vaccine Consumption Volume by Types
7.3 Europe Vaccine Consumption Structure by Application
7.4 Europe Vaccine Consumption by Top Countries
7.4.1 Germany Vaccine Consumption Volume from 2016 to 2021
7.4.2 UK Vaccine Consumption Volume from 2016 to 2021
7.4.3 France Vaccine Consumption Volume from 2016 to 2021
7.4.4 Italy Vaccine Consumption Volume from 2016 to 2021
7.4.5 Russia Vaccine Consumption Volume from 2016 to 2021
7.4.6 Spain Vaccine Consumption Volume from 2016 to 2021
7.4.7 Netherlands Vaccine Consumption Volume from 2016 to 2021
7.4.8 Switzerland Vaccine Consumption Volume from 2016 to 2021
7.4.9 Poland Vaccine Consumption Volume from 2016 to 2021
Chapter 8 South Asia Vaccine Market Analysis
8.1 South Asia Vaccine Consumption and Value Analysis
8.1.1 South Asia Vaccine Market Under COVID-19
8.2 South Asia Vaccine Consumption Volume by Types
8.3 South Asia Vaccine Consumption Structure by Application
8.4 South Asia Vaccine Consumption by Top Countries
8.4.1 India Vaccine Consumption Volume from 2016 to 2021
8.4.2 Pakistan Vaccine Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Vaccine Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Vaccine Market Analysis
9.1 Southeast Asia Vaccine Consumption and Value Analysis
9.1.1 Southeast Asia Vaccine Market Under COVID-19
9.2 Southeast Asia Vaccine Consumption Volume by Types
9.3 Southeast Asia Vaccine Consumption Structure by Application
9.4 Southeast Asia Vaccine Consumption by Top Countries
9.4.1 Indonesia Vaccine Consumption Volume from 2016 to 2021
9.4.2 Thailand Vaccine Consumption Volume from 2016 to 2021
9.4.3 Singapore Vaccine Consumption Volume from 2016 to 2021
9.4.4 Malaysia Vaccine Consumption Volume from 2016 to 2021
9.4.5 Philippines Vaccine Consumption Volume from 2016 to 2021
9.4.6 Vietnam Vaccine Consumption Volume from 2016 to 2021
9.4.7 Myanmar Vaccine Consumption Volume from 2016 to 2021
Chapter 10 Middle East Vaccine Market Analysis
10.1 Middle East Vaccine Consumption and Value Analysis
10.1.1 Middle East Vaccine Market Under COVID-19
10.2 Middle East Vaccine Consumption Volume by Types
10.3 Middle East Vaccine Consumption Structure by Application
10.4 Middle East Vaccine Consumption by Top Countries
10.4.1 Turkey Vaccine Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Vaccine Consumption Volume from 2016 to 2021
10.4.3 Iran Vaccine Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Vaccine Consumption Volume from 2016 to 2021
10.4.5 Israel Vaccine Consumption Volume from 2016 to 2021
10.4.6 Iraq Vaccine Consumption Volume from 2016 to 2021
10.4.7 Qatar Vaccine Consumption Volume from 2016 to 2021
10.4.8 Kuwait Vaccine Consumption Volume from 2016 to 2021
10.4.9 Oman Vaccine Consumption Volume from 2016 to 2021
Chapter 11 Africa Vaccine Market Analysis
11.1 Africa Vaccine Consumption and Value Analysis
11.1.1 Africa Vaccine Market Under COVID-19
11.2 Africa Vaccine Consumption Volume by Types
11.3 Africa Vaccine Consumption Structure by Application
11.4 Africa Vaccine Consumption by Top Countries
11.4.1 Nigeria Vaccine Consumption Volume from 2016 to 2021
11.4.2 South Africa Vaccine Consumption Volume from 2016 to 2021
11.4.3 Egypt Vaccine Consumption Volume from 2016 to 2021
11.4.4 Algeria Vaccine Consumption Volume from 2016 to 2021
11.4.5 Morocco Vaccine Consumption Volume from 2016 to 2021
Chapter 12 Oceania Vaccine Market Analysis
12.1 Oceania Vaccine Consumption and Value Analysis
12.2 Oceania Vaccine Consumption Volume by Types
12.3 Oceania Vaccine Consumption Structure by Application
12.4 Oceania Vaccine Consumption by Top Countries
12.4.1 Australia Vaccine Consumption Volume from 2016 to 2021
12.4.2 New Zealand Vaccine Consumption Volume from 2016 to 2021
Chapter 13 South America Vaccine Market Analysis
13.1 South America Vaccine Consumption and Value Analysis
13.1.1 South America Vaccine Market Under COVID-19
13.2 South America Vaccine Consumption Volume by Types
13.3 South America Vaccine Consumption Structure by Application
13.4 South America Vaccine Consumption Volume by Major Countries
13.4.1 Brazil Vaccine Consumption Volume from 2016 to 2021
13.4.2 Argentina Vaccine Consumption Volume from 2016 to 2021
13.4.3 Columbia Vaccine Consumption Volume from 2016 to 2021
13.4.4 Chile Vaccine Consumption Volume from 2016 to 2021
13.4.5 Venezuela Vaccine Consumption Volume from 2016 to 2021
13.4.6 Peru Vaccine Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Vaccine Consumption Volume from 2016 to 2021
13.4.8 Ecuador Vaccine Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Vaccine Business
14.1 AstraZeneca
14.1.1 AstraZeneca Company Profile
14.1.2 AstraZeneca Vaccine Product Specification
14.1.3 AstraZeneca Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 GSK
14.2.1 GSK Company Profile
14.2.2 GSK Vaccine Product Specification
14.2.3 GSK Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 CCBIO
14.3.1 CCBIO Company Profile
14.3.2 CCBIO Vaccine Product Specification
14.3.3 CCBIO Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 BioNTech
14.4.1 BioNTech Company Profile
14.4.2 BioNTech Vaccine Product Specification
14.4.3 BioNTech Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Elanco
14.5.1 Elanco Company Profile
14.5.2 Elanco Vaccine Product Specification
14.5.3 Elanco Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Boehringer-Ingelheim
14.6.1 Boehringer-Ingelheim Company Profile
14.6.2 Boehringer-Ingelheim Vaccine Product Specification
14.6.3 Boehringer-Ingelheim Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Indian Immunologicals
14.7.1 Indian Immunologicals Company Profile
14.7.2 Indian Immunologicals Vaccine Product Specification
14.7.3 Indian Immunologicals Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 CureVac
14.8.1 CureVac Company Profile
14.8.2 CureVac Vaccine Product Specification
14.8.3 CureVac Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 CSL
14.9.1 CSL Company Profile
14.9.2 CSL Vaccine Product Specification
14.9.3 CSL Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Hulan Bio
14.10.1 Hulan Bio Company Profile
14.10.2 Hulan Bio Vaccine Product Specification
14.10.3 Hulan Bio Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Mylan
14.11.1 Mylan Company Profile
14.11.2 Mylan Vaccine Product Specification
14.11.3 Mylan Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Translate Bio
14.12.1 Translate Bio Company Profile
14.12.2 Translate Bio Vaccine Product Specification
14.12.3 Translate Bio Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 Merck
14.13.1 Merck Company Profile
14.13.2 Merck Vaccine Product Specification
14.13.3 Merck Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 Wuhan Institute of Biological Products
14.14.1 Wuhan Institute of Biological Products Company Profile
14.14.2 Wuhan Institute of Biological Products Vaccine Product Specification
14.14.3 Wuhan Institute of Biological Products Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.15 Plumbline Life Sciences
14.15.1 Plumbline Life Sciences Company Profile
14.15.2 Plumbline Life Sciences Vaccine Product Specification
14.15.3 Plumbline Life Sciences Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.16 Moderna Therapeutics
14.16.1 Moderna Therapeutics Company Profile
14.16.2 Moderna Therapeutics Vaccine Product Specification
14.16.3 Moderna Therapeutics Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.17 Minhai Biotechnology
14.17.1 Minhai Biotechnology Company Profile
14.17.2 Minhai Biotechnology Vaccine Product Specification
14.17.3 Minhai Biotechnology Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.18 Walvax Biotechnology
14.18.1 Walvax Biotechnology Company Profile
14.18.2 Walvax Biotechnology Vaccine Product Specification
14.18.3 Walvax Biotechnology Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.19 Sanofi
14.19.1 Sanofi Company Profile
14.19.2 Sanofi Vaccine Product Specification
14.19.3 Sanofi Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.20 Mitsubishi Tanabe Pharma
14.20.1 Mitsubishi Tanabe Pharma Company Profile
14.20.2 Mitsubishi Tanabe Pharma Vaccine Product Specification
14.20.3 Mitsubishi Tanabe Pharma Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.21 Zoties
14.21.1 Zoties Company Profile
14.21.2 Zoties Vaccine Product Specification
14.21.3 Zoties Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Vaccine Market Forecast (2022-2027)
15.1 Global Vaccine Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Vaccine Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Vaccine Value and Growth Rate Forecast (2022-2027)
15.2 Global Vaccine Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Vaccine Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Vaccine Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Vaccine Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Vaccine Consumption Forecast by Type (2022-2027)
15.3.2 Global Vaccine Revenue Forecast by Type (2022-2027)
15.3.3 Global Vaccine Price Forecast by Type (2022-2027)
15.4 Global Vaccine Consumption Volume Forecast by Application (2022-2027)
15.5 Vaccine Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
